Australia's Arovella Therapeutics falls on discounted placement
** Shares of Arovella Therapeutics ALA.AX fall as much
11.5% to A$0.115, their lowest since Jan. 5
** Biotechnology co to raise A$12.5 mln ($8.17 mln) at
A$0.10 per share
** Issue price represents a 23.1% discount to ALA's last
close
** About 5.2 mln shares change hands, 2.3x the 30-day avg
volume
** Stock up ~13% YTD, as of last close
($1 = 1.5305 Australian dollars)
(Reporting by Neha Soni in Bengaluru)
((Neha.Soni@thomsonreuters.com))
Recent news on Arovella Therapeutics
See all newsBrief: Arovella Therapeutics Appoints Acting CEO
Brief: Arovella Therapeutics Says Michael Baker Resigns As CEO
Brief: Arovella Therapeutics Says Elizabeth Stoner Will Be Retiring As Interim Chair
Brief: Arovella Therapeutics Says IND For Ala-101 Accepted By FDA
Brief: Arovella Therapeutics Appoints Lachie Mallia As CFO